Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-30

FDA Approved: GUANFACINE — Supplemental Application (Sun Pharmaceutical Industries, Inc)

View source ↗

Summary

The FDA approved a supplemental application for guanfacine from Sun Pharmaceutical Industries, Inc., finalizing an updated approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

SUPPL AP for GUANFACINE (GUANFACINE)